Funding
Turn ideas into impact
Show Me
Due: November 15, 2027
Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-336
Due: November 16, 2027
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 – Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-265
Due: November 16, 2027
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 – Clinical Trial Optional)
US $200,000
Type
Grant
Source
Federal
Opp Number
PAR-25-266
Due: November 16, 2027
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
US $100,000
Type
Grant
Source
Federal
Opp Number
PAR-25-122
Due: November 16, 2027
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-244
Due: November 16, 2027
Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R21 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-331
Due: November 18, 2027
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
US $300,000
Type
Grant
Source
Federal
Opp Number
RFA-DA-26-034
Due: November 20, 2027
DEVCOM ARMY RESEARCH LABORATORY BROAD AGENCY ANNOUNCEMENT FOR FOUNDATIONAL RESEARCH
Type
Cooperative Agreement
Source
Federal
Opp Number
W911NF-23-S-0001
Due: December 3, 2027
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
US $275,000
Type
Grant
Source
Federal
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?